GeneBioTech Co. ,Ltd (KOSDAQ: 086060)

GeneBioTech Co. ,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	9,886	8,751	7,430	7,430	8,794	5,624
Short-Term Investments	13,483	13,265	8,660	10,360	18,593	19,415
Cash & Short-Term Investments	23,369	22,016	16,090	17,790	27,387	25,039
Cash Growth	17.71%	36.83%	-9.56%	-35.04%	9.38%	-18.19%
Accounts Receivable	12,711	11,588	14,090	10,225	6,655	7,637
Other Receivables	269.73	180.69	183.82	74.85	80.37	127.81
Receivables	13,023	11,818	14,302	10,371	6,899	7,912
Inventory	17,324	14,802	15,452	13,676	10,441	10,739
Prepaid Expenses	20.92	24.16	25.66	41.05	44.35	118.11
Other Current Assets	886.68	621.38	399.76	298.05	698.85	54.24
Total Current Assets	54,624	49,281	46,269	42,175	45,470	43,862
Property, Plant & Equipment	13,760	14,159	14,615	14,900	12,910	18,769
Long-Term Investments	680.55	718.86	484.19	763.6	1,241	3,107
Goodwill	-	-	589.54	589.54	589.54	589.54
Other Intangible Assets	600.44	632.02	398.29	199.07	198.94	304.33
Long-Term Deferred Tax Assets	53.6	205.29	495.41	870.49	521.64	-
Other Long-Term Assets	280.34	513	666.71	294.23	376.97	383.65
Total Assets	70,469	66,017	64,041	60,368	62,085	67,933
Accounts Payable	3,625	3,540	3,901	4,752	1,671	2,709
Accrued Expenses	1,166	970.5	649.23	515.74	532.03	838.51
Short-Term Debt	10,637	7,704	9,486	8,042	4,352	2,738
Current Portion of Long-Term Debt	2,859	1,534	1,159	-	-	-
Current Portion of Leases	129.24	132.92	42.29	112.39	69.15	80.28
Current Income Taxes Payable	56.83	284.27	14.46	-	237.89	231.33
Current Unearned Revenue	-	-	-	-	1.96	2.08
Other Current Liabilities	199.32	347.33	667.94	716.5	815.97	3,342
Total Current Liabilities	18,673	14,513	15,920	14,139	7,680	9,942
Long-Term Debt	2,145	2,995	2,329	2,113	1,113	14,491
Long-Term Leases	136.47	135.08	12.35	33.57	68.66	15.32
Long-Term Deferred Tax Liabilities	-	-	-	-	-	55.96
Other Long-Term Liabilities	70.94	68.54	53.02	137	2,795	98.2
Total Liabilities	21,054	17,712	18,315	16,423	11,657	24,602
Common Stock	4,305	4,305	4,305	4,305	4,305	4,305
Additional Paid-In Capital	14,576	14,576	14,576	14,489	14,835	14,800
Retained Earnings	30,207	29,059	18,116	16,190	16,844	19,303
Comprensive Income & Other	327.81	364.07	8,729	8,961	9,059	8,521
Total Common Equity	49,416	48,305	45,726	43,945	45,043	46,929
Minority Interest	-	-	-	-	-	-3,598
Shareholders' Equity	49,416	48,305	45,726	43,945	50,428	43,331
Total Liabilities & Equity	70,469	66,017	64,041	60,368	62,085	67,933
Total Debt	15,908	12,502	13,029	10,302	5,603	17,324
Net Cash (Debt)	7,462	9,514	3,061	7,488	21,784	7,714
Net Cash Growth	30.25%	210.80%	-59.12%	-65.62%	182.38%	-44.94%
Net Cash Per Share	867.33	1104.91	355.50	869.68	2529.89	895.90
Filing Date Shares Outstanding	8.61	8.61	8.61	8.61	8.61	8.61
Total Common Shares Outstanding	8.61	8.61	8.61	8.61	8.61	8.61
Working Capital	35,950	34,768	30,349	28,037	37,791	33,920
Book Value Per Share	5738.97	5609.93	5310.44	5103.62	5231.12	5450.16
Tangible Book Value	48,816	47,673	44,738	43,157	44,255	46,035
Tangible Book Value Per Share	5669.24	5536.52	5195.72	5012.04	5139.55	5346.35
Land	7,013	7,061	5,464	5,464	4,115	4,120
Buildings	6,452	6,533	6,489	6,471	4,101	10,427
Machinery	9,499	9,342	9,255	9,222	9,140	17,917
Construction In Progress	9.65	41.65	1,620	1,007	1,935	1,793

Source: S&P Capital IQ. Standard template. Financial Sources.